EQS-News: Equity (NAV) increases by almost EUR 27 million to EUR 277.9 million, corresponding to EUR 64.90 per share. EBIT increases by EUR 2.75 million to EUR 33.0 million. The equity ratio rises to 95.5%.
|
EQS-News: MPH Health Care AG
/ Key word(s): Preliminary Results/Quarter Results
MPH Health Care AG publishes preliminary figures for the 2024 financial year: Equity (net asset value) increases by almost EUR 27 million to EUR 277.9 million, corresponding to EUR 64.90 per share. EBIT increases by EUR 2.75 million to EUR 33.0 million. The equity ratio rises to 95.5%. Berlin, 30th April 2025 - MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated result for the 2024 financial year. Accordingly, equity increased by 10.7% from EUR 251.0 million to EUR 277.9 million. The net asset value (NAV) per share rose from EUR 58.62 (31 December 2023) to EUR 64.90 as of 31 December 2024. In the 2024 financial year, preliminary EBIT increased by 9.1% to EUR 33.0 million (previous year: EUR 30.2 million). The IFRS net profit for the year rose from EUR 29.5 million to EUR 32.0 million. As of 31 December 2024, equity increased by EUR 26.9 million to EUR 277.9 million (previous year: EUR 251.0 million). The equity ratio rose from 94.2% to 95.5% and remains at a very high level. MPH AG is an investment company whose investments are recognised as financial assets under the balance sheet item "Financial assets" and are measured at “fair value through profit or loss” at the balance sheet date. The net profit for the year is mainly the result of the fair value measurement of the listed investments held as of the balance sheet date, which result from the higher market prices of the investments compared to the previous year's balance sheet date. „Despite the current trade disputes with the USA and the ongoing conflict situation in Ukraine, we are confident about developments in 2025. The M1-Group plans to systematically continue its profitable growth by further expanding national and international specialist centres. By 2029, annual sales of EUR 200 to 300 million with an EBIT margin of at least 20% are targeted in the core ‘Beauty’ segment. With its vertically integrated investment portfolio, CR Energy AG is well positioned in the areas of ‘sustainable energy supply concepts’ and ‘quality and cost-optimised living space’. MPH AG can also systematically benefit from the positive developments of the investments in the coming years," says Patrick Brenske, CEO of MPH.
About MPH Health Care AG: MPH Health Care AG is an investment company with a strategic focus on the acquisition, development and sale of companies and company shares, particularly in growth segments of the healthcare market. This includes both insurance-financed and privately financed segments. However, MPH also utilises the potential offered by high-growth and profitable sectors outside the healthcare market. Contact: Patrick Brenske, Management Board Corporate Communications E-Mail: ir@mph-ag.de
30.04.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | MPH Health Care AG |
| Grünauer Straße 5 | |
| 12557 Berlin | |
| Germany | |
| Phone: | 030 / 863 21 45 60 |
| Fax: | 030 / 863 21 45 69 |
| E-mail: | info@mph-ag.de |
| Internet: | www.mph-ag.de |
| ISIN: | DE000A289V03, DE000A289VT5 |
| WKN: | A289V0 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2127140 |
| End of News | EQS News Service |
|
|
2127140 30.04.2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 41,22 | 3,43 | 13,55 | 30,67 | 34,46 | 65,37 | 0,00 | |
| EBITDA1,2 | 11,59 | -70,99 | -9,05 | 29,59 | 29,54 | 32,99 | 0,00 | |
| EBITDA-Margin3 | 28,12 | -2.069,68 | -66,79 | 96,48 | 85,72 | 50,47 | 0,00 | |
| EBIT1,4 | 11,58 | -71,02 | -9,07 | 29,56 | 30,21 | 32,96 | 0,00 | |
| EBIT-Margin5 | 28,09 | -2.070,55 | -66,94 | 96,38 | 87,67 | 50,42 | 0,00 | |
| Net Profit (Loss)1 | 11,08 | -70,38 | -8,96 | 29,11 | 29,54 | 32,04 | 0,00 | |
| Net-Margin6 | 26,88 | -2.051,90 | -66,13 | 94,91 | 85,72 | 49,01 | 0,00 | |
| Cashflow1,7 | -1,35 | -2,89 | -1,09 | 0,01 | -2,02 | 1,83 | 0,00 | |
| Earnings per share8 | 2,60 | -16,44 | -2,09 | 6,80 | 6,90 | 7,48 | -6,90 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 1,20 | 1,20 | 1,20 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: wetreu NTRG
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| MPH Health Care | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A289V0 | DE000A289V03 | AG | 104,47 Mio € | 01.09.2009 | Kaufen | 9F4MCHV9+6R |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 12,20 | 4,89 | 2,49 | 5,60 | 0,38 | 57,12 | 1,60 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 1,20 | 1,20 | 1,20 | 4,92% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 17.07.2025 | 12.06.2025 | 16.09.2025 | 20.11.2025 | 28.05.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +30,42% | +20,39% | +7,96% | -0,81% | +0,00% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
